CluePoints vs Medidata (2026)
Trial oversight is the common purchase behind CluePoints and Medidata, with a different center of gravity. CluePoints concentrates on monitoring, discrepancy investigation and coding review; Medidata places AI across a broader clinical trial platform anchored by Rave data capture. CluePoints combines central monitoring, site oversight, medical review, Intelligent Query Detection and Intelligent Medical Coding. IQD investigates discrepancies across data domains and prepares evidence with editable query text for a data manager to submit to Veeva EDC. IMC suggests MedDRA and WHODrug codes for acceptance or rejection, retaining a decision history. Its accuracy and recall figures lack the test detail needed to establish expected performance on a new study. Medidata Plus connects AI study build, Clinical Data Studio, imaging and the Dot assistant. Teams can generate forms and edit checks, review integrated trial data and investigate signals. Health Record Connect imports patient record information into Rave, with site staff saving the form before submission. Other AI capabilities state human oversight without the same detail on each approval point. CluePoints fits sponsors and CROs adding specialized review and monitoring workflows around their study systems. Medidata fits organizations standardizing capture, study setup and data review within a larger trial platform, with AI capabilities packaged across that environment.
- Central monitoring and discrepancy investigation are the immediate priorities.
- Data managers need editable queries with supporting evidence.
- Medical coders need reviewable MedDRA and WHODrug suggestions.
- A study specific pilot should test selected review modules.
- Rave already anchors clinical trial data capture.
- Study build and data review should share one platform.
- Patient record imports need confirmation inside Rave forms.
- AI capabilities should be purchased across several trial functions.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. CluePoints and Medidata are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | CluePoints | Medidata |
|---|---|---|
| Primary category | Clinical Trials AI | Clinical Trials AI |
| Founded | 2012 | Not recorded |
| Headquarters | Louvain la Neuve, Belgium | New York, New York |
| Website | cluepoints.com | medidata.com |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
CluePoints provides clinical trial data quality and oversight software for pharmaceutical sponsors and contract research organizations. Its suite combines central monitoring, site oversight, medical and safety review, query detection, and medical coding.
Source: AI Health Index, October 2026
New York clinical trial software company, a Dassault Systemes brand, whose platform is anchored by Rave data capture and used across tens of thousands of trials. Since July 2026 its AI capabilities are packaged as Medidata Plus: AI study build that generates forms, edit checks and synthetic test data; Clinical Data Studio for integrated data review, risk and safety signal detection and AI-enabled audit trail review; image handling with automated redaction of identifying text; and the Dot assistant for simulation, forecasting and workflow automation.
Source: AI Health Index, October 2026
Questions buyers ask
How do CluePoints and Medidata work with the EHR?
For CluePoints, the resulting audit history follows detection, evidence review, confirmation, and query action. The wider monitoring platform also ingests clinical, trial management, and safety data, while IMC fits into existing coding workflows.
Clinical Data Studio brings in non-Medidata sources, including third party laboratories and other data capture systems. Data flows one way, from the record into the trial; no named record system, marketplace listing or integration documentation shows a production connection to a specific EHR, and the exchanges are not named. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.
How do CluePoints and Medidata handle patient data?
CluePoints may also anonymize information by removing identifying characteristics and use deidentified or aggregated trial data to develop, test, and maintain its software. IQD adapts through user interaction, so the distinction between operational data use and product improvement matters.
For Medidata, the trust and transparency page says the company does not use data for secondary purposes without the customer's explicit written permission, reviews every internal data use request, and runs a Data Collaboration Program in which aggregated, anonymized data sits in a separate environment. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.
Which settings and specialties do CluePoints and Medidata cover?
With CluePoints, the suite can operate across studies and sponsor portfolios, with GSK named in IQD's development and at least 100 production studies included in its performance claim.
The platform serves biopharmaceutical and medtech sponsors and contract research organizations across study design, build, execution and closeout, with therapeutic area solutions in oncology, vaccines and CNS; Health Record Connect also feeds Medidata Surgical Planning and real world data work that reaches beyond trials. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.
What evidence is published for CluePoints and Medidata?
For CluePoints, the number of production studies does not supply those missing denominators. Earlier SMART research and the historical FDA collaboration concern different technology from today's query detection and coding releases.
With Medidata, the company says its AI has supported more than 500 studies; that describes use, not benefit. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Trials AI page.
CluePoints is based in Louvain la Neuve, Belgium, and operates following EQT's majority investment. New York based Medidata is a Dassault Systemes brand. Neither has public subscription prices; headline efficiency figures lack full evaluation methods.